Arcadia Biosciences (NASDAQ:RKDA) is set to issue its quarterly earnings data after the market closes on Wednesday, March 27th. Analysts expect the company to announce earnings of ($0.76) per share for the quarter.

RKDA opened at $7.20 on Monday. The firm has a market cap of $34.38 million, a P/E ratio of -1.05 and a beta of -1.97. Arcadia Biosciences has a fifty-two week low of $2.64 and a fifty-two week high of $34.99.

RKDA has been the subject of several research analyst reports. HC Wainwright set a $20.00 target price on shares of Arcadia Biosciences and gave the company a “buy” rating in a research note on Thursday, December 13th. Zacks Investment Research cut shares of Arcadia Biosciences from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, February 13th.

TRADEMARK VIOLATION NOTICE: This story was first published by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another site, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark laws. The original version of this story can be read at https://www.watchlistnews.com/arcadia-biosciences-rkda-scheduled-to-post-quarterly-earnings-on-wednesday/2915466.html.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, an agricultural food ingredient company, develops and commercializes health and nutrition ingredient traits worldwide. The company offers a suite of agricultural productivity traits, including nitrogen use efficiency, water use efficiency and drought tolerance, salinity tolerance, and herbicide tolerance traits.

See Also: Can individual investors take part in an IPO?

Earnings History for Arcadia Biosciences (NASDAQ:RKDA)

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.